In recent years, the Japanese medical sector has strongly emerged as a global leader with growing strengths in clinical research and state of the art medical equipment. In the field of cancer research, the National Cancer Center of Japan (NCC) is leveraging collaborations with multiple domestic and international partners to drive forward innovation in new drug discovery. To learn more about NCC’s critical role, Washington CORE spoke to Dr. Toshihiko Doi, Director of NCC’s Exploratory Oncology Research & Clinical Trial Center (EPOC).